Does TRILACICLIB Cause Myelosuppression? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Myelosuppression have been filed in association with TRILACICLIB (COSELA). This represents 10.6% of all adverse event reports for TRILACICLIB.
24
Reports of Myelosuppression with TRILACICLIB
10.6%
of all TRILACICLIB reports
2
Deaths
20
Hospitalizations
How Dangerous Is Myelosuppression From TRILACICLIB?
Of the 24 reports, 2 (8.3%) resulted in death, 20 (83.3%) required hospitalization, and 2 (8.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
Haemorrhage (11)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which TRILACICLIB Alternatives Have Lower Myelosuppression Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE